Currently, studies of GLP-1s for PCOS are inconclusive due to small sample population and heterogenicity between trials
Focus on nutrient-dense options that provide steady energy throughout the day
Interestingly, W-24 (106), a non-peptide GLP-1RA, has been reported to inhibit inflammatory pain by stimulating the spinal cord GLP-1R for the release of analgesic -endorphin
#Watch #GLP1 #WeightLossDrugs #PharmaNews #IndianPharma #Semaglutide #Mounjaro #Wegovy #Ozempic #PatentExpiry #HealthcareBusiness #CNBCTV18Digital Transcript To view or add a comment, sign in More Relevant Posts Ozempic patents expire March 2026, triggering 50% price drops in India, China, Brazil
Fibromyalgia affects approximately 2-4% of the U.S
This is where prebiotics come in